查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1263972

支架的全球市場:趨勢，機會，競爭分析(2022年～2027年)

Stent Market: Trends, Opportunities and Competitive Analysis [2022-2027]
出版日期: | 出版商: Lucintel | 英文 181 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球支架的市場規模，2027年成為142億美元，從2022年到2027年的預測期間內的年複合成長率成為6.5％。介入性心臟學和末稍血管手術增加，縮短高風險傳統手術患者的治療時間的技術進步，促進市場成長。

本報告提供全球支架市場的相關調查，市場動態，市場趨勢，企業簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場背景與分類

  • 簡介，背景，分類
  • 供應鏈
  • 產業的推動因素與課題

第3章 市場趨勢與預測分析(2016年～2027年)

  • 宏觀經濟的趨勢與預測
  • 全球支架市場趨勢與預測
  • 全球支架市場:各產品類型
    • 冠狀動脈支架
    • 末梢血管支架
  • 全球支架市場:各技術
    • 傳統金屬支架
    • 藥物釋放型血管支架
    • 生物可吸收支架
  • 全球支架市場:各材料
    • 金屬
    • 聚合物
  • 全球支架市場:各最終用途

第4章 市場趨勢與預測分析:各地區

  • 全球支架市場:各地區
  • 北美的支架市場
  • 歐洲的支架市場
  • 亞太地區的支架市場
  • 其他的支架市場

第5章 競爭的分析

  • 產品系列分析
  • 市場佔有率分析
  • 運用整合
  • 地理範圍
  • 波特的五力分析

第6章 成本結構分析

  • 銷售原價
  • 販管費
  • EBITDA獲利率

第7章 成長機會及策略分析

  • 成長機會分析
    • 全球支架市場成長機會:各產品類型
    • 全球支架市場成長機會:各技術
    • 全球支架市場成長機會:各材料
    • 全球支架市場成長機會:各地區
  • 全球支架市場上新的趨勢
  • 策略分析
    • 新產品的開發
    • 全球支架市場生產能力擴大
    • 全球支架市場的合併，收購，合資企業

第8章 主要企業簡介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic Public Limited Company
  • C. R. Bard, Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health Inc.
  • Stryker Corporation
  • Johnson & Johnson
  • Edwards Life Sciences Corporation
簡介目錄

Stent Market Trends and Forecast

The future of the global stent market looks promising with opportunities in the segments of hospital and ambulatory surgical centers. The global stent market is expected to reach an estimated $14.2 billion by 2027 with a CAGR of 6.5% from 2022 to 2027. The major growth drivers for this market are increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.

Emerging Trends in the Stent Market

Emerging trends which have a direct impact on the dynamics of the market include increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents.

A total of 83 figures / charts and 74 tables are provided in this 181-page report to help in your business decisions. Sample figures with some insights are shown below.

Stent Market by Segments

In this market, hospital is the largest application market, whereas coronary stent is largest market by product type. Growth in various segments of the stent market is given below:

The study includes a trend and forecast for the stent market by product type, material, technology, end use, and region as follows:

Stent Market by Product Type [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • Coronary Stents
  • Peripheral Vascular Stents

Stent Market By Material [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • Metal
  • Polymer

Stent Market By Technology [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • Bare Metal Stents
  • Drug Eluting Stents
  • Bioreabsorbable Stents

Stent Market by End Use [Value ($ Million)]:

  • Hospital
  • Ambulatory Surgical Center

Stent Market by Region [Value ($ Million) and Volume (Million Units) from 2016 to 2027]:

  • North America

United States

Canada

Mexico

  • Europe

Germany

France

United Kingdom

Italy

Spain

  • APAC

China

India

Japan

  • ROW

Brazil

List of Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stent companies profiled in this report include.

  • Abbott Laboratory
  • Boston Scientific
  • Medtronic public limited company
  • C R Bard
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health

Stent Market Insights

  • Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders.
  • Within the global stent market, the drug eluting stent segment will remain the largest market by technology during the forecast period due to low restenosis rate after surgery. Bioreabsorbable stent is expected to witness the highest growth during the forecast period due to its property of getting absorbed in the body.
  • By material, the global stent market is segmented into metal and polymer. The polymer segment is expected to remain the largest segment in the forecast period.
  • North America is expected to remain the largest market during the forecast period mainly due to its well-developed healthcare infrastructure and continued technological advancements across the healthcare industry.

Features of the Stent Market

  • Market Size Estimates: Stent market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2016-2021) and forecast (2022-2027) by various segments and regions.
  • Segmentation Analysis:Stent market size by various segments, such as product type, material, technology, and end use.
  • Regional Analysis: Stent market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different product type, material, technology, end use, and regions for stent market.
  • Strategic Analysis: This includes M&A and competitive landscape for the stent.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the stent market size?

Answer:The global stent market is expected to reach an estimated $14.3 billion by 2027.

Q2. What is the growth forecast for stent market?

Answer:The stent market is expected to grow at a CAGR of ~6.5% from 2022 to 2027.

Q3. What are the major drivers influencing the growth of the stent market?

Answer: The major growth drivers for this market are increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.

Q4. What are the major applications or end use industries for stent?

Answer:Hospital and Ambulatory Surgical Center are the major end use for stent

Q5. What are the emerging trends in stent market?

Answer:Emerging trends which have a direct impact on the dynamics of the market include increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents.

Q6. Who are the key stent companies?

Answer:Some of the key stent companies are as follows:

  • Abbott Laboratory
  • Boston Scientific
  • Medtronic public limited company
  • C R Bard
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health

Q7.Which stent product segment will be the largest in future?

Answer: Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders.

Q8. In stent market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region and is expected to witness the highest growth over next 5 years

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising potential, high-growth opportunities for the stent market by product type (coronary stent and peripheral vascular stent), material (metal and polymer), technology (bare metal stent, drug eluting stent, and bioreabsorbable stent), end use (hospital and ambulatory surgical center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2 Which segments will grow at a faster pace and why?
  • Q.3 Which regions will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the stent market?
  • Q.5 What are the business risks and threats to the stent market?
  • Q.6 What are emerging trends in this stent market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the stent market?
  • Q.8 What are the new developments in the stent market? Which companies are leading these developments?
  • Q.9 Who are the major players in the stent market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in the stent market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M&A activities did take place in the last five years in the stent market?

Table of Contents

1.Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2016 to 2027

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Stent Market Trends and Forecast
  • 3.3: Global Stent Market by Product Type
    • 3.3.1: Coronary Stent
    • 3.3.2: Peripheral Vascular Stents
  • 3.4: Global Stent Market by Technology
    • 3.4.1: Bare Metal Stents
    • 3.4.2: Drug Eluting Stents
    • 3.4.3: Bioreabsorbable Stents
  • 3.5: Global Stent Market by Material
    • 3.5.1: Metal
    • 3.5.2: Polymer
  • 3.6: Global Stent Market by End Use

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Stent Market by Region
  • 4.2: North American Stent Market
    • 4.2.1 Market by Product Type: Coronary and Peripheral Vascular Stents.
    • 4.2.2 Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stents.
    • 4.2.3 Market by Material: Metal and Polymer.
    • 4.2.4 United States Stent Market
    • 4.2.5 Mexican Stent Market
    • 4.5.6 Canadian Stent Market
  • 4.3: European Stent Market
    • 4.3.1 Market by Product Type: Coronary and Peripheral Vascular Stents
    • 4.3.2 Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stent
    • 4.3.3 Market by Material: Metal and Polymer.
    • 4.3.4 German Stent Market
    • 4.3.5 French Stent Market
    • 4.3.6 United Kingdom Stent Maret
    • 4.4.7 Italian Stent Market
    • 4.4.8 Spanish Stent Market
  • 4.5: APAC Stent Market
    • 4.5.1: Market by Product Type: Coronary and Peripheral Vascular Stents.
    • 4.5.2: Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stents
    • 4.5.3: Market by Material: Metal and Polymer
    • 4.5.4: Japanese Stent Market
    • 4.5.5: Chinese Stent Market
    • 4.5.6: Indian Stent Market
  • 4.6: ROW Stent Market
    • 4.6.1: Market by Product Type: Coronary and Peripheral Vascular Stents
    • 4.6.2: Market by Technology: Bare Metal, Drug Eluting, and Bioreabsorbable Stents
    • 4.6.3:Market by Material: Metal and Polymer
    • 4.6.4: Brazilian Stent Market

5. Competitor Analysis

  • 5.5: Product Portfolio Analysis
  • 5.6: Market Share Analysis
  • 5.7: Operational Integration
  • 5.8: Geographical Reach
  • 5.9: Porter's Five Forces Analysis

6. Cost Structure Analysis

  • 6.1: Cost of Goods Sold
  • 6.2: SG&A
  • 6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis

  • 7.1: Growth Opportunity Analysis
    • 7.1.1: Growth Opportunities for the Global Stent Market by Product Type
    • 7.1.2: Growth Opportunities for the Global Stent Market by Technology
    • 7.1.3: Growth Opportunities for the Global Stent Market by Material
    • 7.1.4: Growth Opportunities for the Global Stent Market by Region
  • 7.2: Emerging Trends in the Global Stent Market
  • 7.3: Strategic Analysis
    • 7.3.1: New Product Development
    • 7.3.2: Capacity Expansion of the Global Stent Market
    • 7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stent Market

8. Company Profiles of Leading Players

  • 8.1: Abbott Laboratories
  • 8.2: Boston Scientific Corporation
  • 8.3: Medtronic Public Limited Company
  • 8.4: C. R. Bard, Inc.
  • 8.5: Cook Medical Inc.
  • 8.6: Terumo Corporation
  • 8.7: Cardinal Health Inc.
  • 8.8: Stryker Corporation.
  • 8.9: Johnson & Johnson
  • 8.10: Edwards Life Sciences Corporation